Published in N Engl J Med on November 19, 1992
Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A (1999) 6.05
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis (2013) 2.99
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol (2006) 2.88
Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol (2000) 2.50
Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood (2011) 2.49
Global control of hepatitis C: where challenge meets opportunity. Nat Med (2013) 2.22
B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis. Hepatology (2012) 2.05
Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol (2007) 2.00
Cryoglobulins. J Clin Pathol (2002) 1.85
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A (2005) 1.76
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood (2007) 1.72
Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol (2000) 1.70
Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol (2002) 1.66
Hepatitis C virus-induced cryoglobulinemia. Kidney Int (2009) 1.60
Hepatitis C: a review for primary care physicians. CMAJ (2006) 1.60
Mixed cryoglobulinemia. Orphanet J Rare Dis (2008) 1.52
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut (1999) 1.44
Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol (1997) 1.42
Increased prevalence of reduced estimated glomerular filtration rate in chronic hepatitis C patients. Dig Dis Sci (2010) 1.38
Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37
Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol (2006) 1.28
Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol (2007) 1.22
Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn (2000) 1.19
Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol (2003) 1.18
Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A (1997) 1.15
Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples. J Clin Microbiol (2001) 1.15
Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin Exp Immunol (1996) 1.13
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol (2013) 1.13
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology (2015) 1.10
Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. J Clin Microbiol (1999) 1.09
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol (2003) 1.08
Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis (2001) 1.06
Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J (2011) 1.06
Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis (1998) 1.06
Nonhepatic manifestations and combined diseases in HCV infection. Dig Dis Sci (1996) 1.06
Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol (2012) 1.04
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol (1994) 1.02
Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus. J Clin Microbiol (1996) 1.01
Persisting mixed cryoglobulinemia in Chikungunya infection. PLoS Negl Trop Dis (2009) 1.00
Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population. J Neurol Neurosurg Psychiatry (2006) 0.99
Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J Virol (2005) 0.99
Cryoglobulins are not essential. Ann Rheum Dis (1998) 0.99
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol (2001) 0.99
Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol (2005) 0.97
Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J (2011) 0.97
Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection. J Virol (2003) 0.96
Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia. Clin Exp Immunol (2000) 0.95
Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry. World J Gastroenterol (2005) 0.95
Management of patients with hepatitis C infection and renal disease. World J Hepatol (2015) 0.95
Hepatitis C virus infection and mixed cryoglobulinemia. Clin Dev Immunol (2012) 0.94
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy. Clin Dev Immunol (2012) 0.93
A simplified method for Ca2+ flux measurement on isolated human B cells that uses flow cytometry. Clin Diagn Lab Immunol (1997) 0.92
Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol (2002) 0.92
The role of humoral innate immunity in hepatitis C virus infection. Viruses (2012) 0.91
Cryoglobulinemia related to hepatitis C virus infection. Dig Dis Sci (2007) 0.90
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. Medicine (Baltimore) (2013) 0.90
Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients. Clin Diagn Lab Immunol (1994) 0.89
Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry (1996) 0.89
Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum (2013) 0.89
Autoimmune manifestations in viral hepatitis. Semin Immunopathol (2012) 0.88
Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis (2011) 0.88
Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy. N Am J Med Sci (Boston) (2014) 0.88
An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol (2013) 0.87
Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci (1996) 0.87
Hepatitis C virus and cryoglobulinemia. N Engl J Med (1993) 0.86
Hepatitis C virus infection in nephrology patients. J Nephropathol (2013) 0.86
Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature. World J Gastroenterol (2006) 0.86
Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins. Clin Exp Immunol (2006) 0.86
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group. Clin Exp Immunol (1998) 0.86
Effect of hepatitis C virus coinfection on humoral immune alterations in naïve HIV-infected adults on HAART: a three year follow-up study. J Clin Immunol (2005) 0.85
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. Clin Dev Immunol (2012) 0.85
CD81 and hepatitis C virus (HCV) infection. Viruses (2014) 0.84
Cross-linking of Fc(gamma)-receptor on monocytes inhibits hepatitis C virus-specific cytotoxic T-lymphocyte induction in vitro. Immunology (1998) 0.84
Rituximab-based treatment, HCV replication, and hepatic flares. Clin Dev Immunol (2012) 0.84
Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity. Ann Rheum Dis (1998) 0.83
Update on chronic viral hepatitis. Postgrad Med J (2001) 0.83
Peripheral B cells as reservoirs for persistent HCV infection. Front Microbiol (2011) 0.83
Clinical significance of serum hepatitis C virus (HCV) RNA as marker of HCV infection. J Clin Microbiol (1994) 0.83
Renal dysfunction associated with liver transplantation. Postgrad Med J (1995) 0.83
Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol (2008) 0.83
Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence. Scientifica (Cairo) (2012) 0.83
Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls. J Virol (2007) 0.83
Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia. Clin Exp Immunol (2002) 0.82
Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment. World J Gastroenterol (2013) 0.82
Hepatitis C virus infection and its rheumatologic implications. Gastroenterol Hepatol (N Y) (2014) 0.82
Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy. J Clin Transl Hepatol (2015) 0.82
Hepatitis C virus: molecular biology and genetic variability. Dig Dis Sci (1996) 0.81
HCV infection and B-cell lymphomagenesis. Adv Hematol (2011) 0.81
Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment. J Virol (2004) 0.81
Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies. Gastroenterol Hepatol (N Y) (2007) 0.81
IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia. Clin Exp Immunol (1993) 0.81
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr (2014) 0.81
Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients. Medicine (Baltimore) (2013) 0.81
A case of cutaneous vasculitis with underlying hepatitis C and cryoglobulinaemia. Ulster Med J (2008) 0.81
Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease. Am J Pathol (2007) 0.81
Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 9.36
Complementation of the temperature-sensitive defect in H5ts125 adenovirus DNA replication in vitro. Proc Natl Acad Sci U S A (1979) 2.70
Effectiveness of current technology in the diagnosis and management of lower gastrointestinal hemorrhage. Gastrointest Endosc (1995) 1.85
Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis. J Viral Hepat (2009) 1.75
Viral hepatocarcinogenesis. Oncogene (2010) 1.73
Increasing handwashing compliance with more accessible sinks. Infect Control (1986) 1.61
Replication of adenovirus type 2 DNA in vitro. Proc Natl Acad Sci U S A (1977) 1.58
The leptin era: new insight into the mechanisms of body weight homeostasis. J Pediatr Gastroenterol Nutr (1999) 1.57
Adenovirus DNA replication in soluble extracts of infected cell nuclei. Cold Spring Harb Symp Quant Biol (1979) 1.53
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation (2001) 1.38
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol (2001) 1.34
Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest (1988) 1.31
Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond) (2013) 1.24
Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA. Biochem Biophys Res Commun (1999) 1.16
Viruses and thrombotic microangiopathy. Transplantation (1999) 1.05
Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus. J Med Virol (1999) 1.04
Spontaneous rupture of ureter. Urology (1987) 1.04
Idiopathic giant esophageal ulcers in a renal transplant patient responsive to steroid therapy. Transplantation (2000) 1.03
Changes in serum ghrelin predict weight loss after Roux-en-Y gastric bypass in rats. Surg Endosc (2005) 1.01
Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation (1998) 0.99
Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology (1997) 0.99
Allograft dysfunction and hyperbilirubinemia in a liver transplant recipient. Transpl Infect Dis (2000) 0.98
Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol (1999) 0.97
Metastases to the adrenal glands and the development of Addison's disease. Cancer (1984) 0.96
Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci (1998) 0.95
Serum leptin in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (1998) 0.93
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin. Aliment Pharmacol Ther (2011) 0.91
Characterization of full-length hepatitis C virus genotype 4 sequences. J Viral Hepat (2007) 0.90
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population. J Viral Hepat (2009) 0.88
Specific alpha 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity. Circ Res (1990) 0.88
Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes. J Pharmacol Exp Ther (1989) 0.88
Acute hepatitis C infection lowers serum lipid levels. J Viral Hepat (2011) 0.87
The effect of verapamil in reducing the severity of acute tubular necrosis in canine renal autotransplants. Transplantation (1987) 0.83
Response to symptom-limited exercise in patients with the hepatopulmonary syndrome. Chest (1998) 0.81
Tissue-specific sex differences in galanin-like immunoreactivity and galanin mRNA during development in the rat. Peptides (1989) 0.81
Increase in plasma leptin and Lep mRNA concentrations by food intake is dependent on insulin. Metabolism (1998) 0.81
Sexually dimorphic expression of the growth hormone-releasing hormone gene is not mediated by circulating gonadal hormones in the adult rat. Endocrinology (1991) 0.80
Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline. Am J Cardiol (1983) 0.79
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team. HIV Med (2007) 0.79
Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy. AIDS Clin Rev (2000) 0.79
HCV synergizes with body weight in the promotion of insulin resistance. J Viral Hepat (2011) 0.78
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study. J Viral Hepat (2012) 0.78
Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation (1997) 0.78
Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis. J Acquir Immune Defic Syndr (2010) 0.78
Estrogen increases galanin immunoreactivity in hyperplastic prolactin-secreting cells in Fisher 344 rats. Endocrinology (1990) 0.78
Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas. Am J Pathol (1991) 0.77
Interleukin 1 beta initially sensitizes and subsequently protects murine intestinal stem cells exposed to photon radiation. Cancer Res (1991) 0.77
Domino liver transplantation in maple syrup urine disease: a case report and review of the literature. Transplant Proc (2012) 0.77
Galanin-like immunoreactivity is influenced by estrogen in peripubertal and adult rats. Neuroendocrinology (1990) 0.76
Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis. Am J Transplant (2014) 0.76
Regulation of leptin expression and secretion by corticosteroids and insulin. Implications for body weight. Endocrine (1998) 0.76
HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease. Aliment Pharmacol Ther (2015) 0.76
Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation. Liver Transpl (2000) 0.76
Association between abdominal wall defects and cryptorchidism. J Urol (1986) 0.76
Parenterally transmitted hepatitis: viruses, vaccines, and antiviral therapy. Compr Ther (1993) 0.75
Regulation of anterior pituitary galanin gene expression by thyroid hormone. Brain Res Mol Brain Res (1997) 0.75
[Pneumoconiosis in Kuzbass coal miners]. Ter Arkh (1974) 0.75
[Prevention and treatment of pneumonia in infectious complications of trauma]. Vestn Khir Im I I Grek (1988) 0.75
Methods for the study of sequence-specific binding of proteins to the HCV RNA genome. Methods Mol Med (1999) 0.75
Subdural hematoma and cerebral infarction (non-hemorrhagic): relative efficacy of computerized tomography and brain scanning in their detection. Hawaii Med J (1980) 0.75
Management of portal hypertension and its complications. Med Clin North Am (1996) 0.75